Novome Biotechnologies Funding: $33M Raised, Series A (2020)
Novome Biotechnologies is based in South San Francisco. It has raised $33M in total funding. Latest round: Series A.
Novome Biotechnologies funding overview
Novome Biotechnologies is based in South San Francisco. Novome Biotechnologies has raised $33M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2020. The round record for Novome Biotechnologies runs through 2020; nothing later has been disclosed. Investors on record include DCVC Bio, 5AM Ventures, Alta Partners, Alexandria Venture Investments, Mayo Clinic. 5 distinct backers are named across the disclosed rounds.
Novome Biotechnologies at a glance
Total raised
$33M
Latest round
Series A
Latest round date
January 2020
Headquarters
South San Francisco
Notable investors
DCVC Bio, 5AM Ventures, Alta Partners, Alexandria Venture Investments, Mayo Clinic
Frequently asked about Novome Biotechnologies funding
How much has Novome Biotechnologies raised?
Novome Biotechnologies has raised $33M in total disclosed funding across the rounds on record.
Who has invested in Novome Biotechnologies?
DCVC Bio, 5AM Ventures, Alta Partners, Alexandria Venture Investments, Mayo Clinic are named among the investors backing Novome Biotechnologies.
What was the latest Novome Biotechnologies funding round?
The most recent disclosed round is a Series A, announced in January 2020.
Where is Novome Biotechnologies based?
Novome Biotechnologies is based in South San Francisco.
When did Novome Biotechnologies last raise?
The last disclosed Novome Biotechnologies round closed in January 2020 at Series A.
Totals shown for Novome Biotechnologies aggregate every disclosed round on file. To see how that compares, browse the companies in South San Francisco and the investors behind them below.
